Cellebrite DI .(US:CLBT)2024-08-16 00:51Financial Performance Highlights - Total Revenue for Q2 2024 reached $96 million, a 25% increase compared to $77 million in Q2 2023[5] - Subscription Revenue for Q2 2024 was $85 million, showing a 27% growth from $67 million in Q2 2023[5] - Annual Recurring Revenue (ARR) as of June 2024 was $346 million, a 26% increase from $274 million in June 2023[5] - Adjusted EBITDA for Q2 2024 was $22 million, representing 23% of revenue, compared to $11 million and 15% in Q2 2023[5] Revenue Breakdown and Growth - Subscription revenue constitutes a significant portion of total revenue, accounting for 88%-89% in recent quarters[12, 13] - Other non-recurring revenue, including hardware sales, usage fees, and perpetual licenses, makes up the remaining 11%-12%[12, 13] - Total revenue growth was 25%, driven by a 27% increase in total subscription revenue in Q2 2024[13] Financial Forecast - The company anticipates ARR to be between $366 million and $374 million for Q3 2024 and between $388 million and $400 million for the full year 2024[22] - Revenue is projected to be between $100 million and $104 million for Q3 2024 and between $390 million and $398 million for the full year 2024[22] - Adjusted EBITDA is expected to be between $25 million and $29 million for Q3 2024 and between $90 million and $95 million for the full year 2024[22] Cash Position - The company's cash position as of June 30, 2024, was $366 million, including cash and cash equivalents, deposits, and short-term and long-term marketable securities[19] - This represents an increase of $18.7 million from Q1 2024 and $121.4 million from Q2 2023[19]